U.S. Markets closed
  • S&P 500

    +33.11 (+0.75%)
  • Dow 30

    +382.20 (+1.09%)
  • Nasdaq

    +73.91 (+0.50%)
  • Russell 2000

    -8.52 (-0.37%)
  • Gold

    -29.80 (-1.66%)

    +0.0005 (+0.0464%)
  • 10-Yr Bond

    +0.0570 (+3.75%)
  • Vix

    -0.56 (-3.32%)

    +0.0074 (+0.5418%)

    +0.5230 (+0.4601%)

    -234.78 (-0.38%)
  • CMC Crypto 200

    +57.32 (+4.07%)
  • FTSE 100

    +26.32 (+0.37%)
  • Nikkei 225

    +517.70 (+1.81%)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts EHang Holdings Limited (EH) Investors to Monday, April 19th Deadline in Securities Class Action, Company Releases Disappointing Earnings

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN FRANCISCO, CA / ACCESSWIRE / April 16, 2021 / Hagens Berman urges EHang Holdings Limited (NASDAQ:EH) investors with significant losses to submit their losses now.

Class Period: Dec. 9, 2019 - Feb. 16, 2021

Lead Plaintiff Deadline: Apr. 19, 2021


Contact An Attorney Now:EHang@hbsslaw.com


EHang Holdings Limited (EH) Securities Litigation:

The Complaint alleges that throughout the Class Period, Defendants misrepresented and concealed that: (i) E-Hang's purported regulatory approvals in Europe and North American for its EH216 were for use as a drone, and not for carrying passengers; (ii) its relationship with its purported primary customer, Kunxiang, is a sham; (iii) EHang has only collected on a fraction of its reported sales since its ADS began trading on NASDAQ in December 2019; and (iv) the Company's manufacturing facilities were practically empty and lacked evidence of advanced manufacturing equipment or employees.

Investors allegedly learned the truth on February 16, 2021, when analyst Wolfpack Research issued a scathing report about the company. Wolfpack Research contends that Kunxiang has entered into sham contracts to benefit EH's stock price. Wolfpack Research also alleges that EH has exaggerated revenues by reporting sales for which it cannot collect. Wolfpack Research further avers that EH makes false claims about regulatory approvals the company has purportedly received, misleadingly suggesting the company has commercial approval for its products.

On this news, the price of EHang's shares dropped $77.79 per share (or 62.7%) in one trading day.

Most recently, on Apr. 16, 2021, EHang released disappointing 4Q 2020 earnings, reporting paltry revenue growth and a 15% decline in sales of its EH216 as compared to 4Q 2019.

"We're focused on investor losses and proving EH lied about its revenues, customers and regulatory approvals," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are an EH investor, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding EH should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email EHang@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP

View source version on accesswire.com: